Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2013.607 | Dyslipidemia International Study II (DYSIS II) | Dr Yan Bryan Ping Yen |
| 2013.082 | Physiologic-Guided Endovascular Revascularization for the Treatment of Atherosclerotic Erectile Dysfunction in Chinese Patients with Suboptimal Response to Pharmacotherapy: A Pilot Study | Prof. YAN Bryan Ping Yen |
| 2012.561 | Novel Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule | Prof. YAN Bryan Ping Yen |
| 2014.332 | A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting. (RE-DUAL PCI) | Prof. YAN Bryan Ping Yen |
| 2013.420 | Transcatheter Renal Denervation with an over-the-wire balloon based technology for Patiemts with Resistant Hypertension | Prof. YAN Bryan Ping Yen |
| 2014.210 | Randomized controlled trial and cost-effectiveness analysis of targeted rapid screening for atrial fibrillation using a handheld single-lead ECG device with automated diagnostics and tailored stroke prevention strategy for screen-detected patients | Prof. YAN Bryan Ping Yen |
| 2012.481 | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome | Prof. YAN Bryan Ping Yen |
| 2013.586 | GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation (Phase II/III) | Prof. YAN Bryan Ping Yen |
| 2013.658 | A PHASE 3 DOUNLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDMIA AT RISK OF CARDIOVASCULAR EVENTS | Prof. YAN Bryan Ping Yen |
| 2011.178 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Prof. YAN Bryan Ping Yen |
| 2015.302 | ASTRI Wireless ECG Module Public Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.296 | International Survey on Current Status & Future of Drug-Eluting Stents |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.297 | Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.301 | Effects of Cardiovascular Autonomic Nervous System Activities on BP/ECG/PPG/Respiratory Related Physiological Features, Validation of Improved PTT-based Cuffless BP Estimation with IEEE 1708 Standard, and Measurement of Respiratory Rate with a Novel Method |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.291 | Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2015.292 | A novel non-invasive radial artery tonometric cardiovascular monitoring device for assessment of vascular aging, subclinical atherosclerosis and cardiovascular risk in the elderly. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.366 | ACCelerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.638 | Defining the athletes heart phenotype: A comparison of male Caucasian and East Asian elite footballers and rugby players |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.258 | A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo | Prof. YAN Bryan Ping Yen |
| 2017.316 | Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy | Prof. YAN Bryan Ping Yen |
| 2016.370 | Patient education, monitoring and support to enhance adherence to dabigatran in patients with non-valvular atrial fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.623 | Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong | Dr. YAN Bryan Ping Yen |
| 2016.401 | BIOTRONIKS - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris - Registry: BIOSOLVE-IV | Dr. YAN Bryan Ping Yen |
| 2016.531 | Prospective Observational study of Lipid Management in Non-US, Non-Western European Patients Who Have A Recent Acute Coronary Syndrome Event |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2014.603 | HK-GP AF Screening & Education Program | Prof. YAN Bryan Ping Yen |
| 2016.265 | The Effect of CYP2C19 Genetic Variants on Clinical Outcomes in Post-Angioplasty Patients Treated with Clopidogrel |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.380 | A pilot study to assess efficacy and safety of a novel Titanium-Nitride coated woven-nitinol Peripheral Arterial Stent | Prof. YAN Bryan Ping Yen |
| 2014.653 | Changing Pattern of Revascularization for Critical Limb Ischemia towards an Endovascular First Approach in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2016.550 | Validation of Camera-based Measurement of Finger & Facial Photoplethysmographic Signal for Heart Rate and Arrhythmias Detection |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.542 | East Asian ALDH2 polymorphism and impact on myocardial infarct size |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.630 | Renal Artery Sympathetic Denervation by Catheter Ablation after Pulmonary Vein Isolation (PVI) for Persistent Atrial Fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.509 | Hong Kong Percutaneous Coronary Intervention Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.456 | Diagnostic Accuracy and Incremental Prognostic Value of Exercise MCG in Patients at Risk of Coronary Artery Disease |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.490 | Development of personalized medicine using Prenetics iGenes pharmacogenomic panel to predict individual responses to cardiovascular drugs |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.003 | Implantation of the Venus P-ValveTM in the Pulmonic Position in Patients with Native Outflow Tracts |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.266 | Novel Serum Biomarkers Associated with Atherosclerosis-related Vascular Diseases: A Translational Approach | Prof. YAN Bryan Ping Yen |
| 2014.381 | Multinational Abluminal Sirolimus Coated BiO-Engineered StenT – The MASCOT Post Marketing Registry | Dr. YAN Bryan Ping Yen |
| 2016.319 | Investigation on the novel noninvasive sensors and algorithms for validating cuffless continuous blood pressure measurement. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.234 | PWH Cardiac Implantable Electronic Devices (CIED) Home Monitoring Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.358 | Optical Coherence Tomography evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris | Prof. YAN Bryan Ping Yen |
| 2024.251 | BIOTRONIK – Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (Freesolve) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A randomized controlled trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.152 | Rationale and design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.242 | A single arm, multicenter, open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in participants who completed the parent Lp(a)HORIZON trial | Prof. YAN Bryan Ping Yen |
| 2024.339 | Investigations of cardiotoxicity in cancer survivors | Prof. YAN Bryan Ping Yen |
| 2024.468 | AI-Based Intima-Media Thickness Measurement for Cardiovascular Risk Assessment |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.212 | Retrospective Database Study for Treatment Patterns of Lipid-lowering Therapy in Patients with Hypercholesterolemia or Mixed Dyslipidemia in Hong Kong, South Korea, and Taiwan (READY Study) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.156 | A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.695 | Validation of a new non-invasive oscillometric device for capillary blood pressure measurement |
Dr. YAN Bryan 甄秉言 |
| 2015.538 | A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696 |
Prof. YAN Bryan 甄秉言教授 |
| 2009.167 | Chinese Translation and Validation of the Walking Impairment Questionnaire in Patients with Peripheral Arterial Disease | Prof. YAN Bryan |
Page 18 of 264.